• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.46% Nasdaq Down2.35%

    Nymox Pharmaceutical Corporation (NYMX)

    3.62 Up 0.46(14.56%) 12:14PM EDT - Nasdaq Real Time Price
    ProfileGet Profile for:
    Nymox Pharmaceutical Corporation
    Bay & Deveaux Streets
    Bahamas - Map
    Website: http://www.nymox.com

    Index Membership:N/A
    Industry:Diagnostic Substances
    Full Time Employees:N/A

    Business Summary 

    Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer’s disease. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in Phase III clinical trials for the treatment of enlarged prostate or benign prostatic hyperplasia, as well as is in Phase II clinical trial for low grade localized prostate cancer. The company markets its products in Canada, the United States, Europe, and internationally. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, The Bahamas.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Nymox Pharmaceutical Corporation

    Key Executives 
    Dr. Paul Averback M.D., DABP, 65
    Founder, Chairman, Chief Exec. Officer, Pres, Member of Communications Committee and Member of Corp. Governance Committee
    Mr. Erik Danielsen , 53
    Chief Financial Officer
    Mr. Randall J. Lanham Esq., 52
    Gen. Counsel, Sec., Lead Independent Director and Chairman of Corp. Governance Committee
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders